Founders
The co-founders of Consilienta
Dr. Elena Meurer
co-founder & principal consultant managing director
Elena brings over 25 years of academic, industry and consulting experience. She provides strategic, CMC and regulatory consulting for products at all development stages and across various regulatory regions. Elena has supported multiple products through various clinical development phases, including Marketing Authorization Applications (MAAs), Biologics License Applications (BLAs) preparations, and national hospital exemptions. She has successfully guided companies in obtaining GMP manufacturing licenses and establishing CDMO activities. Elena also contributed to projects aimed at raising regulatory standards in third countries and delivered training to relevant regulatory agencies.
Dr. Elena Meurer
co-founder & principal consultant managing director
Elena brings over 25 years of academic, industry and consulting experience. She provides strategic, CMC and regulatory consulting for products at all development stages and across various regulatory regions. Elena has supported multiple products through various clinical development phases, including Marketing Authorization Applications (MAAs), Biologics License Applications (BLAs) preparations, and national hospital exemptions. She has successfully guided companies in obtaining GMP manufacturing licenses and establishing CDMO activities. Elena also contributed to projects aimed at raising regulatory standards in third countries and delivered training to relevant regulatory agencies.
Dr. Elena Meurer
co-founder & principal consultant managing director
Elena brings over 25 years of academic, industry and consulting experience. She provides strategic, CMC and regulatory consulting for products at all development stages and across various regulatory regions. Elena has supported multiple products through various clinical development phases, including Marketing Authorization Applications (MAAs), Biologics License Applications (BLAs) preparations, and national hospital exemptions. She has successfully guided companies in obtaining GMP manufacturing licenses and establishing CDMO activities. Elena also contributed to projects aimed at raising regulatory standards in third countries and delivered training to relevant regulatory agencies.
Dr. Liron Sarid-Krebs
co-founder & principal consultant managing director
Liron has nearly two decades of experience in consulting, biotech industry, and academia. She has deep expertise in designing and executing global regulatory strategies for innovative medicinal products from early development through to registration. Liron has led global consultancy teams and overseen clinical development and regulatory consulting activities across various regions. She has successfully guided companies through complex global development processes, including orphan and pediatric indications. Liron provides scientific, regulatory, and strategic support for expedited development and approval pathways, orphan designation and maintenance, pediatric development plans, and any clinical and regulatory documentation required for clinical trial and marketing approvals.
Dr. Liron Sarid-Krebs
co-founder & principal consultant managing director
Liron has nearly two decades of experience in consulting, biotech industry, and academia. She has deep expertise in designing and executing global regulatory strategies for innovative medicinal products from early development through to registration. Liron has led global consultancy teams and overseen clinical development and regulatory consulting activities across various regions. She has successfully guided companies through complex global development processes, including orphan and pediatric indications. Liron provides scientific, regulatory, and strategic support for expedited development and approval pathways, orphan designation and maintenance, pediatric development plans, and any clinical and regulatory documentation required for clinical trial and marketing approvals.
Dr. Liron Sarid-Krebs
co-founder & principal consultant managing director
Liron has nearly two decades of experience in consulting, biotech industry, and academia. She has deep expertise in designing and executing global regulatory strategies for innovative medicinal products from early development through to registration. Liron has led global consultancy teams and overseen clinical development and regulatory consulting activities across various regions. She has successfully guided companies through complex global development processes, including orphan and pediatric indications. Liron provides scientific, regulatory, and strategic support for expedited development and approval pathways, orphan designation and maintenance, pediatric development plans, and any clinical and regulatory documentation required for clinical trial and marketing approvals.
Dr. Tiina Palomäki
co-founder & principal consultant
Tiina has 25+ years of biotech experience in regulatory agency, consulting services and academia. She is an ex-regulator of Finnish Medicines Agency (Fimea) and EMA (CAT, GTWP, CPWP, SWP) with expertise in ATMPs and biotech products. She provides scientific and global regulatory strategic support, nonclinical and clinical development support, including alternative non-animal methodologies. She provides regulatory and scientific support for agency interactions such as scientific advice, clinical trial applications (CTA, IND), and marketing authorization applications (MAA, BLA) across the regions.
Dr. Tiina Palomäki
co-founder & principal consultant
Tiina has 25+ years of biotech experience in regulatory agency, consulting services and academia. She is an ex-regulator of Finnish Medicines Agency (Fimea) and EMA (CAT, GTWP, CPWP, SWP) with expertise in ATMPs and biotech products. She provides scientific and global regulatory strategic support, nonclinical and clinical development support, including alternative non-animal methodologies. She provides regulatory and scientific support for agency interactions such as scientific advice, clinical trial applications (CTA, IND), and marketing authorization applications (MAA, BLA) across the regions.
Dr. Tiina Palomäki
co-founder & principal consultant
Tiina has 25+ years of biotech experience in regulatory agency, consulting services and academia. She is an ex-regulator of Finnish Medicines Agency (Fimea) and EMA (CAT, GTWP, CPWP, SWP) with expertise in ATMPs and biotech products. She provides scientific and global regulatory strategic support, nonclinical and clinical development support, including alternative non-animal methodologies. She provides regulatory and scientific support for agency interactions such as scientific advice, clinical trial applications (CTA, IND), and marketing authorization applications (MAA, BLA) across the regions.
About Consilienta
